Adaptimmune Therapeutics PLC
OTC:ADAPY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Adaptimmune Therapeutics PLC
OTC:ADAPY
|
UK |
|
N
|
Neooto Co Ltd
KOSDAQ:212560
|
KR |
|
Green Planet Group Inc
OTC:GNPG
|
US |
|
PBF Energy Inc
NYSE:PBF
|
US |
|
B
|
Biofish Holding AS
OSE:BFISH
|
NO |
|
EV Resources Ltd
ASX:EVR
|
AU |
|
S
|
Sanigen Co Ltd
KOSDAQ:188260
|
KR |
|
Panca Mitra Multiperdana Tbk PT
IDX:PMMP
|
ID |
|
E
|
Enity Holding AB (publ)
STO:ENITY
|
SE |
|
Carisma Therapeutics Inc
NASDAQ:CARM
|
US |
|
Mode Global Holdings PLC
F:MOC
|
UK |
|
D
|
Dragon Group International Ltd
SGX:MT1
|
SG |
|
P
|
Pacific Silk Road Resources Group Inc
XTSX:PP
|
CA |
Bankruptcy Probability
Adaptimmune Therapeutics PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Adaptimmune Therapeutics PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
|
9.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
443.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
226.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
65.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Adaptimmune Therapeutics PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Adaptimmune Therapeutics PLC has total debt of 25.7m USD. This includes both short-term (0 USD) and long-term (25.7m USD) debt.
You can find a full breakdown on its Balance Sheet.
